C.A. Lawton

7.4k total citations · 3 hit papers
83 papers, 4.4k citations indexed

About

C.A. Lawton is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, C.A. Lawton has authored 83 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 39 papers in Radiation and 20 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in C.A. Lawton's work include Prostate Cancer Diagnosis and Treatment (44 papers), Prostate Cancer Treatment and Research (44 papers) and Advanced Radiotherapy Techniques (39 papers). C.A. Lawton is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (44 papers), Prostate Cancer Treatment and Research (44 papers) and Advanced Radiotherapy Techniques (39 papers). C.A. Lawton collaborates with scholars based in United States, Canada and United Kingdom. C.A. Lawton's co-authors include Miljenko V. Pilepich, David J. Grignon, Mack Roach, William U. Shipley, Richard K. Valicenti, Michael J. Seider, Gerald E. Hanks, Sucha O. Asbell, Roger W. Byhardt and X. Allen Li and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

C.A. Lawton

79 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

1997 492 citations C.A. Lawton, Gerald E. Hanks et al. profile →
Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

2003 471 citations Mack Roach, Michelle DeSilvio et al. profile →
Short-Term Neoadjuvant Androgen Deprivation Therapy and External-Beam Radiotherapy for Locally Advanced Prostate Cancer: Long-Term Results of RTOG 8610

2008 451 citations Mack Roach, Kyounghwa Bae et al. profile →

Peers

C.A. Lawton

PRM

RADIA

RNMI

SURGE

ONCOL

C.A. Lawton United States

Gert De Meerleer Belgium

Alberto Bossi France

Valérie Fonteyne Belgium

Jean‐Léon Lagrange France

Roy H. Decker United States

Stanley L. Liauw United States

Do Hoon Lim South Korea

Yee Ung Canada

R. Bryan Rumble United States

C.A. Lawton United States

C.A. Lawton

5.2k ×1.6

PRM

2.1k ×1.2

RADIA

819 ×0.9

RNMI

831 ×1.7

SURGE

680 ×1.4

ONCOL

Citations per year, relative to C.A. Lawton C.A. Lawton (= 1×) peers C.A. Lawton

Countries citing papers authored by C.A. Lawton

Since Specialization

Citations

This map shows the geographic impact of C.A. Lawton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.A. Lawton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.A. Lawton more than expected).

Fields of papers citing papers by C.A. Lawton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.A. Lawton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.A. Lawton. The network helps show where C.A. Lawton may publish in the future.

Co-authorship network of co-authors of C.A. Lawton

This figure shows the co-authorship network connecting the top 25 collaborators of C.A. Lawton. A scholar is included among the top collaborators of C.A. Lawton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.A. Lawton. C.A. Lawton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hall, William A., Angela Mathison, Michael Tschannen, et al.. (2024). Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations. International Journal of Radiation Oncology*Biology*Physics. 120(2). 570–578.

Mora, Javier, Michael Straza, Bradley A. Erickson, et al.. (2023). Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Advances in Radiation Oncology. 8(4). 101206–101206. 2 indexed citations

Ritter, Mark A., Patrick A. Kupelian, Daniel G. Petereit, et al.. (2020). A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer. Practical Radiation Oncology. 10(5). 345–353. 4 indexed citations

Ahunbay, E, et al.. (2019). Indications of Online Adaptive Replanning Based On Organ Deformation. Practical Radiation Oncology. 10(2). e95–e102. 8 indexed citations

Kershaw, Lucy, Linda G.W. Kerkmeijer, C.A. Lawton, et al.. (2016). MRI-guided prostate adaptive radiotherapy – A systematic review. Radiotherapy and Oncology. 119(3). 371–380. 117 indexed citations

Li, X. Allen, Feng Liu, A. Tai, et al.. (2011). Development of an online adaptive solution to account for inter- and intra-fractional variations. Radiotherapy and Oncology. 100(3). 370–374. 31 indexed citations

Cohen, Eric P., Meena Bedi, Amy A. Irving, et al.. (2011). Mitigation of Late Renal and Pulmonary Injury After Hematopoietic Stem Cell Transplantation. International Journal of Radiation Oncology*Biology*Physics. 83(1). 292–296. 52 indexed citations

Lawton, C.A., Daniel Hunt, W. Robert Lee, et al.. (2011). Long-Term Results of a Phase II Trial of Ultrasound-Guided Radioactive Implantation of the Prostate for Definitive Management of Localized Adenocarcinoma of the Prostate (RTOG 98-05). International Journal of Radiation Oncology*Biology*Physics. 81(1). 1–7. 38 indexed citations

Rodrigues, George, Kyounghwa Bae, Mack Roach, et al.. (2010). Impact of Ultrahigh Baseline PSA Levels on Biochemical and Clinical Outcomes in Two Radiation Therapy Oncology Group Prostate Clinical Trials. International Journal of Radiation Oncology*Biology*Physics. 80(2). 445–452. 13 indexed citations

10.

Lawton, C.A., Jeff M. Michalski, Issam El Naqa, et al.. (2008). RTOG GU Radiation Oncology Specialists Reach Consensus on Pelvic Lymph Node Volumes for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(2). 383–387. 317 indexed citations

11.

Lawton, C.A., Jeff M. Michalski, Issam El Naqa, et al.. (2008). Variation in the Definition of Clinical Target Volumes for Pelvic Nodal Conformal Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 74(2). 377–382. 59 indexed citations

12.

Ahunbay, E, Peng Cheng, Guang‐Pei Chen, et al.. (2008). An on-line replanning scheme for interfractional variationsa). Medical Physics. 35(8). 3607–3615. 102 indexed citations

13.

Fleshner, Neil, et al.. (2007). Adjuvant androgen deprivation therapy augments cure and long-term cancer control in men with poor prognosis, nonmetastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 11(1). 46–52. 10 indexed citations

14.

Abdel–Wahab, May, Brian Berkey, Awtar Krishan, et al.. (2006). Influence of Number of CAG Repeats on Local Control in the RTOG 86-10 Protocol. American Journal of Clinical Oncology. 29(1). 14–20. 16 indexed citations

15.

Lawton, C.A., Michelle DeSilvio, W. Robert Lee, et al.. (2006). Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (Radiation Therapy Oncology Group 98-05). International Journal of Radiation Oncology*Biology*Physics. 67(1). 39–47. 33 indexed citations

16.

Lawton, C.A.. (2003). Hormones and radiation therapy in locally advanced adenocarcinoma of the prostate. Seminars in Radiation Oncology. 13(2). 141–151. 2 indexed citations

17.

Keever-Taylor, Carolyn A., Christopher Bredeson, Fausto R. Loberiza, et al.. (2001). Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: Effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biology of Blood and Marrow Transplantation. 7(11). 620–630. 51 indexed citations

18.

Lawton, C.A., David J. Grignon, Jeffrey H. Newhouse, Paul F. Schellhammer, & Deborah A. Kuban. (1999). Oncodiagnosis Panel: 1997. Radiographics. 19(1). 185–203. 1 indexed citations

19.

Cohen, Eric P., C.A. Lawton, & John E. Moulder. (1995). Bone Marrow Transplant Nephropathy: Radiation Nephritis Revisited. The Nephron journals/Nephron journals. 70(2). 217–222. 77 indexed citations

20.

Ash, Robert C., James T. Casper, Christopher R. Chitambar, et al.. (1990). Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated Donors. New England Journal of Medicine. 322(8). 485–494. 211 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact